Overview

This trial is active, not recruiting.

Condition parkinson disease
Treatment completion of scales evaluation
Sponsor Centre Hospitalier Universitaire, Amiens
Start date October 2015
End date July 2017
Trial size 60 participants
Trial identifier NCT02824367, 2013-A01302-43, PI2014_843_0002

Summary

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety. Also, clinicians reported that they exhibit specific personality traits (e.g., rigidity and perfectionism).

To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's disease showing promising results. Recently, perfectionism has received particular attention because of it association with many emotional disorders. Thus, some psychometric tools have been developed in order to evaluate different aspects of perfectionism. Yet, none of them has been used in people with Parkinson's disease.

The objective of this study is to investigate whether there is a direct link between Parkinson's disease and perfectionism by using psychometric tools from the CBT literature. Identifying such link would allow to justify the use of CBT in people with Parkinson's disease with the goal in mind to improve their care and quality of life.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Intervention model parallel assignment
Masking open label
Arm
(Other)
Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
completion of scales evaluation
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))
(Other)
Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
completion of scales evaluation
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))

Primary Outcomes

Measure
Perfectionism evaluation 1
time frame: Day 0
Perfectionism evaluation 2
time frame: Day 0

Secondary Outcomes

Measure
Depression and anxiety evaluation 1
time frame: Day 0
Depression and anxiety evaluation 2
time frame: Day 0

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Age greater than 18 years - Score Mini Mental Scale (MMS) greater than 23 - For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3 - The control patients present dystonias not within the scope of Parkinson - Informed Consent Form signed - Patient covered by social insurance Exclusion Criteria: - Proven Presence of neuropsychological disorders - Patients with deep brain stimulation - Diagnosis of somatic pathology diagnosed - Private Patient freedom or protected adult (under guardianship)

Additional Information

Official title Evaluation of Clinical Perfectionism in Parkinson Disease
Principal investigator Pierre KRYSTKOWIAK, MD, PhD
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens.